LAL augmentation was able to decrease atherosclerosis in a murine model (LDLR knock-out mice) (Du et al., 2004) and the use of recombinant LAL for the treatment of atherosclerosis continues to be investigated (Grabowski and Du, n.d.). This evidence concerns the gene LIPA and atherosclerosis.